Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron R Hansen

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Cancer Reports (Hoboken, N.J.)|August 24, 2021
Out-of-pocket costs associated with head and neck cancer treatmentMohemmed N Khan, Katrina Hueniken, Mirko Manojlovic-Kolarski, et al.
Oral Oncology|July 18, 2016
A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancerSjoukje F Oosting, Tom W W Chen, Shao H Huang, et al.
Cancer Medicine|March 3, 2020
Cancer patients' experiences with immune checkpoint modulators: A qualitative studyKari Ala-Leppilampi, Natalie A Baker, Chris McKillop, et al.
Cancer|October 1, 2021
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancersJianjun Ren, Wendu Pang, Katrina Hueniken, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Controversies in the management of clinical stage 1 testis cancerGregory J Nason, Peter Chung, Padraig Warde, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 11, 2024
Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled TrialJohn R de Almeida, Rosemary Martino, Ali Hosni, et al.
Investigational New Drugs|June 13, 2016
Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001)Amy Prawira, Irene Brana-Garcia, Anna Spreafico, et al.
Current Oncology (Toronto, Ont.)|January 20, 2021
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsD Gwyn Bebb, Shantanu Banerji, Normand Blais, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Clinical dilemmas in local and regional testis cancerGregory J Nason, Ricardo A Rendon, Lori Wood, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Cancer Reports (Hoboken, N.J.)|August 24, 2021
Out-of-pocket costs associated with head and neck cancer treatmentMohemmed N Khan, Katrina Hueniken, Mirko Manojlovic-Kolarski, et al.
Oral Oncology|July 18, 2016
A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancerSjoukje F Oosting, Tom W W Chen, Shao H Huang, et al.
Cancer Medicine|March 3, 2020
Cancer patients' experiences with immune checkpoint modulators: A qualitative studyKari Ala-Leppilampi, Natalie A Baker, Chris McKillop, et al.
Cancer|October 1, 2021
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancersJianjun Ren, Wendu Pang, Katrina Hueniken, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Controversies in the management of clinical stage 1 testis cancerGregory J Nason, Peter Chung, Padraig Warde, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 11, 2024
Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled TrialJohn R de Almeida, Rosemary Martino, Ali Hosni, et al.
Investigational New Drugs|June 13, 2016
Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001)Amy Prawira, Irene Brana-Garcia, Anna Spreafico, et al.
Current Oncology (Toronto, Ont.)|January 20, 2021
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsD Gwyn Bebb, Shantanu Banerji, Normand Blais, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Clinical dilemmas in local and regional testis cancerGregory J Nason, Ricardo A Rendon, Lori Wood, et al.
Pageof 18